Allworth Financial’s PAVmed PAVM Stock Holding History
Bought
Maintained
Sold
Other funds holding PAVM
TSC
SS
Allworth Financial's PAVM Position: Q2 2026 in Review
Allworth Financial reduced its PAVmed (PAVM) stake by 17% in Q2 2026, selling an estimated $7 and leaving 5 shares worth $30. The position accounts for ﹤0.01% of the portfolio, ranked #5085.
Allworth Financial first reported a position in PAVM in Q1 2020 and has held it in 24 quarters since. The position peaked at $102K in Q3 2021. 19 funds tracked by Wall St. Rank hold PAVM as of Q2 2026.
- Allworth Financial held 5 shares of PAVmed worth $30 as of Q2 2026.
- Allworth Financial sold 1 PAVmed share in Q2 2026, an estimated $7.
- PAVmed made up ﹤0.01% of Allworth Financial's portfolio in Q2 2026, its #5085 holding.
- Allworth Financial first reported a position in PAVmed in Q1 2020 and has held it in 24 quarters since.
- Allworth Financial's PAVmed position peaked at $102K in Q3 2021.
- 19 funds tracked by Wall St. Rank held PAVmed as of Q2 2026.
Based on Allworth Financial's 13F filing for Q2 2026, filed 11 Aug 2026.